Glimepiride, Pioglitazone and Metformin

Strengths:

1 mg + 15 mg + 500 mg

1 mg + 15 mg + 1000 mg

2 mg + 15 mg + 500 mg

2 mg + 15 mg + 1000 mg

Dosage Form: Tablets

Description:

This combination of Glimepiride, Pioglitazone, and Metformin is used to improve glycemic control in adults with type 2 diabetes mellitus. It works by increasing insulin sensitivity, decreasing hepatic glucose production, and stimulating insulin release.

Key Features:

• Triple-action formula for better blood sugar control
• Helps reduce insulin resistance
• Suitable for patients requiring combination therapy
• Convenient once-daily dosing in most cases

Precautions:

• Monitor blood glucose levels regularly
• Risk of hypoglycemia, especially when used with other antidiabetics
• Not recommended in patients with severe renal or hepatic impairment